Abstract:Pulmonary arterial hypertension (PAH) is a life‐threatening lung disease which is characterized by pulmonary vascular remodeling due to the abnormal proliferation of vascular smooth muscle cell (SMCs) and overproduction of extracellular matrix (ECM) proteins including collagen. It has been shown that a number of growth factors such as platelet‐derived growth factor (PDGF) as well as the metabolic shift in energy production from oxidative phosphorylation to glycolysis participate in PAH in animal models and patients. We recently reported that calpain mediates collagen synthesis and proliferation of pulmonary arterial SMCs (PASMCs) contributing to the pathogenesis of PAH. The aim of this study is to investigate the mechanisms by which glycolytic shift induces calpain activation in PAH. PASMCs were incubated with PDGF‐BB (10 ng/ml) for 24 h, after which protein content of 6‐Phosphofructo‐2‐kinase/fructose‐2, 6‐bisphosphatase 3 (PFKFB3) and lactate concentration in the cell lysates and in the culture medium were measured. We found that PDGF‐BB significantly increases the protein levels of PFKFB3 and the lactate production. Our results also showed that inhibition of PFKFB3 attenuates PDGF‐induced calpain activity, collagen synthesis and proliferation of PASMCs. Treatment of PASMCs with lactate markedly increased the activities of calpain and extracellular signal–regulated kinase (ERK) without affecting the protein levels of calpain‐1, calpain‐2 and calpastatin in PASMCs suggesting that it may regulate the calpain activity via posttranslational mechanism. Moreover, inhibition of calpain‐2, but not calpain‐1, attenuates the lactate‐induced collagen synthesis and proliferation of PASMCs. In addition, pre‐treatment of the PASMCs with ERK 1/2 inhibitor PD98059 diminishes increases in calpain‐2 phosphorylation at serine 50, collagen synthesis and proliferation of PASMCs induced by lactate. More importantly, pharmacological inhibition of ERK 1/2 by PD98059 attenuates the progression of Sugen/Hypoxia‐induced pulmonary hypertension and pulmonary vascular remodeling in rats. In summary, we have demonstrated that ERK‐stimulated calpain signaling is a critical pathway in PAH which mediates cell proliferation and collagen synthesis in pulmonary vascular smooth muscle cells via enhanced glycolysis. Support or Funding Information Supported by NIH (YS), Department of Veterans Affairs (YS), FAMRI (YS) and AHA (LK). This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension

Epigenetic Regulation of Pulmonary Arterial Hypertension

Abstract 14566: the Role of Eosinophils in Pulmonary Hypertension

Regulatory role of autophagy in development of pulmonary artery hypertension

Endogenous Retroviral Elements Generate Pathologic Neutrophils and Elastase Rich Exosomes in Pulmonary Arterial Hypertension

Immune cell-derived serine protease as pathogenic drivers of vascular remodeling in pulmonary arterial hypertension

Mechanisms of lung endothelial cell injury and survival in pulmonary arterial hypertension

Role of extracellular matrix in the pathogenesis of pulmonary arterial hypertension.

The role of chemokines and chemokine receptors in pulmonary arterial hypertension

Endothelial cells in the pathogenesis of pulmonary arterial hypertension

Angiotensin-converting Enzyme Defines Matrikine-Regulated Inflammation and Fibrosis

Abstract 159: Endothelial Fatty Acid-binding Proteins Contribute to the Pathogenesis of Pulmonary Hypertension

Endothelial Cell Energy Metabolism, Proliferation, and Apoptosis in Pulmonary Hypertension

Role of macrophages in pulmonary arterial hypertension

Immune Cells in Pulmonary Arterial Hypertension.

Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial Hypertension.

Single-Cell Transcriptome Analysis of Peripheral Neutrophils From Patients With Idiopathic Pulmonary Arterial Hypertension

Increased Glycolysis Contributes to Pulmonary Vascular Remodeling via ERK-dependent Calpain Activation in Pulmonary Arterial Hypertension

Role of the Immune System Elements in Pulmonary Arterial Hypertension

The role of platelets in the development and progression of pulmonary arterial hypertension

Expression of Peptide Fragments from Proadm and Involvement of Mitogen-Activated Protein Kinase Signaling Pathways in Pulmonary Remodeling Induced by High Pulmonary Blood Flow